Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Run-Lin Gao

Showing results (221-230 of 308) with videos related to

Pageof 31
Sort By:
Zhonghua Yi Xue Za Zhi|December 2, 2008
[Effects of sirolimus-eluting stent and the paclitaxel-eluting stent: a three-year follow-up study]Zhan Gao, Yue-jin Yang, Ji-lin Chen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 23, 2008
[Effects of treating ostial left anterior descending artery stenosis by drug eluting stents via precisely positioning or crossing over into left main stem]Zhan Gao, Yue-jin Yang, Ji-lin Chen, et al.
Chinese Medical Journal|February 4, 2006
Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteriesJi-lin Chen, Run-lin Gao, Yue-jin Yang, et al.
Coronary Artery Disease|October 17, 2008
Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stentJue Chen, Jian-Jun Li, Ji-Lin Chen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|January 13, 2009
[Outcome of patients implanted with bioabsorbable polymer sirolimus-eluting stent (Excel) and the durable polymer sirolimus-eluting stent (Cypher)]Zhan GAO, Yue-jin YANG, Ji-lin CHEN, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|August 23, 2007
[Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis]Ji-Lin Chen, Yue-Jin Yang, Shu-Bin Qiao, et al.
Chinese Medical Journal|August 25, 2005
The influence of diabetes mellitus on the procedural and in-hospital outcomes after elective percutaneous coronary interventionChong-jian Li, Run-lin Gao, Yue-jin Yang, et al.
Zhonghua Yi Xue Za Zhi|December 3, 2005
[Short and long-term therapeutic effects of rapamycin-eluting stent and paclitaxel-eluting stent in treatment of coronary disease with complicated lesions]Ji-lin Chen, Run-lin Gao, Yue-jin Yang, et al.
Thrombosis Research|October 12, 2016
CYP2C19 genotyping combined with on-clopidogrel platelet reactivity in predicting major adverse cardiovascular events in Chinese patients with percutaneous coronary interventionXiao-Fang Tang, Ya-Ling Han, Jia-Hui Zhang, et al.
Chinese Medical Journal|September 2, 2009
ST-elevated acute myocardial infarction happening 1 month post stent implantation: late thrombosis in-stents or new lesions?Guang-yuan Song, Yue-jin Yang, Bo Xu, et al.
Pageof 31

Showing results (221-230 of 308) with videos related to

Sort By:
Pageof 31
Zhonghua Yi Xue Za Zhi|December 2, 2008
[Effects of sirolimus-eluting stent and the paclitaxel-eluting stent: a three-year follow-up study]Zhan Gao, Yue-jin Yang, Ji-lin Chen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 23, 2008
[Effects of treating ostial left anterior descending artery stenosis by drug eluting stents via precisely positioning or crossing over into left main stem]Zhan Gao, Yue-jin Yang, Ji-lin Chen, et al.
Chinese Medical Journal|February 4, 2006
Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteriesJi-lin Chen, Run-lin Gao, Yue-jin Yang, et al.
Coronary Artery Disease|October 17, 2008
Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stentJue Chen, Jian-Jun Li, Ji-Lin Chen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|January 13, 2009
[Outcome of patients implanted with bioabsorbable polymer sirolimus-eluting stent (Excel) and the durable polymer sirolimus-eluting stent (Cypher)]Zhan GAO, Yue-jin YANG, Ji-lin CHEN, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|August 23, 2007
[Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis]Ji-Lin Chen, Yue-Jin Yang, Shu-Bin Qiao, et al.
Chinese Medical Journal|August 25, 2005
The influence of diabetes mellitus on the procedural and in-hospital outcomes after elective percutaneous coronary interventionChong-jian Li, Run-lin Gao, Yue-jin Yang, et al.
Zhonghua Yi Xue Za Zhi|December 3, 2005
[Short and long-term therapeutic effects of rapamycin-eluting stent and paclitaxel-eluting stent in treatment of coronary disease with complicated lesions]Ji-lin Chen, Run-lin Gao, Yue-jin Yang, et al.
Thrombosis Research|October 12, 2016
CYP2C19 genotyping combined with on-clopidogrel platelet reactivity in predicting major adverse cardiovascular events in Chinese patients with percutaneous coronary interventionXiao-Fang Tang, Ya-Ling Han, Jia-Hui Zhang, et al.
Chinese Medical Journal|September 2, 2009
ST-elevated acute myocardial infarction happening 1 month post stent implantation: late thrombosis in-stents or new lesions?Guang-yuan Song, Yue-jin Yang, Bo Xu, et al.
Pageof 31